ADPT
Price:
$4.27
Market Cap:
$629.71M
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals; and T-Detect COVID for the confirmation of past COVID-19 infection. It also provides clonoSEQ, a clinical diagnostic product for the detection and monitoring of minimal residual disease in patients with multiple myeloma, B cell acute lymphoblastic leukemia, and chronic lymphocytic leukemia, as well as available as a CLIA-validated laboratory develo...[Read more]
Industry
Biotechnology
IPO Date
2019-06-27
Stock Exchange
NASDAQ
Ticker
ADPT
According to Adaptive Biotechnologies Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -2.90. This represents a change of -1.13% compared to the average of -2.93 of the last 4 quarters.
The mean historical PE Ratio of Adaptive Biotechnologies Corporation over the last ten years is -44.48. The current -2.90 PE Ratio has changed 551.96% with respect to the historical average. Over the past ten years (40 quarters), ADPT's PE Ratio was at its highest in in the March 2024 quarter at -2.39. The PE Ratio was at its lowest in in the September 2018 quarter at -128.65.
Average
-44.48
Median
-35.18
Minimum
-99.20
Maximum
-3.14
Discovering the peaks and valleys of Adaptive Biotechnologies Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 57.93%
Maximum Annual PE Ratio = -3.14
Minimum Annual Increase = -65.53%
Minimum Annual PE Ratio = -99.20
Year | PE Ratio | Change |
---|---|---|
2023 | -3.14 | -58.90% |
2022 | -7.64 | -60.10% |
2021 | -19.15 | -65.53% |
2020 | -55.56 | 57.93% |
2019 | -35.18 | -61.54% |
2018 | -91.48 | -7.79% |
The current PE Ratio of Adaptive Biotechnologies Corporation (ADPT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-9.98
5-year avg
-24.14
10-year avg
-44.48
Adaptive Biotechnologies Corporation’s PE Ratio is less than Verve Therapeutics, Inc. (-2.45), greater than Beam Therapeutics Inc. (-13.42), less than Caribou Biosciences, Inc. (-1.26), greater than Sana Biotechnology, Inc. (-4.82), greater than VectivBio Holding AG (-7.94), less than Kinnate Biopharma Inc. (-1.13), less than Royalty Pharma plc (19.23), less than Ikena Oncology, Inc. (-1.22), less than CohBar, Inc. (-0.20), less than Hepion Pharmaceuticals, Inc. (-0.15), less than Rain Therapeutics Inc. (-0.62), less than Krystal Biotech, Inc. (49.72), less than AVROBIO, Inc. (2.07), less than Enveric Biosciences, Inc. (-0.36), less than Elevation Oncology, Inc. (-0.93), greater than Zura Bio Limited (-9.00), less than Reneo Pharmaceuticals, Inc. (-0.85), greater than Legend Biotech Corporation (-30.94), less than Vir Biotechnology, Inc. (-2.19), greater than Apellis Pharmaceuticals, Inc. (-15.28),
Company | PE Ratio | Market cap |
---|---|---|
-2.45 | $473.47M | |
-13.42 | $1.92B | |
-1.26 | $155.42M | |
-4.82 | $1.12B | |
-7.94 | $1.06B | |
-1.13 | $124.99M | |
19.23 | $12.86B | |
-1.22 | $81.56M | |
-0.20 | $1.25M | |
-0.15 | $4.20M | |
-0.62 | $44.01M | |
49.72 | $5.29B | |
2.07 | $5.24M | |
-0.36 | $4.53M | |
-0.93 | $36.94M | |
-9.00 | $230.86M | |
-0.85 | $47.80M | |
-30.94 | $9.90B | |
-2.19 | $1.06B | |
-15.28 | $5.00B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adaptive Biotechnologies Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Adaptive Biotechnologies Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Adaptive Biotechnologies Corporation's PE Ratio?
How is the PE Ratio calculated for Adaptive Biotechnologies Corporation (ADPT)?
What is the highest PE Ratio for Adaptive Biotechnologies Corporation (ADPT)?
What is the 3-year average PE Ratio for Adaptive Biotechnologies Corporation (ADPT)?
What is the 5-year average PE Ratio for Adaptive Biotechnologies Corporation (ADPT)?
How does the current PE Ratio for Adaptive Biotechnologies Corporation (ADPT) compare to its historical average?